Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature

Y Xu, J Qiao - Journal of healthcare engineering, 2022 - Wiley Online Library
The polycystic ovary syndrome (PCOS) is the disease featured by elevated levels of
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

[HTML][HTML] Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention

O Osibogun, O Ogunmoroti, ED Michos - Trends in cardiovascular …, 2020 - Elsevier
Although polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders
affecting women, its etiology is not entirely understood. Clinical symptoms of PCOS include …

Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan

AE Stanhewicz, MM Wenner… - American Journal of …, 2018 - journals.physiology.org
Diseases of the cardiovascular system are the leading cause of morbidity and mortality in
men and women in developed countries, and cardiovascular disease (CVD) is becoming …

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

G Conway, D Dewailly… - European journal of …, 2014 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common ovarian disorder associated with
androgen excess in women, which justifies the growing interest of endocrinologists. Great …

Insulin and the polycystic ovary syndrome

D Macut, J Bjekić-Macut, D Rahelić, M Doknić - Diabetes research and …, 2017 - Elsevier
Polycystic ovary syndrome (PCOS) is the most prevalent endocrinopathy among women
during reproductive age. PCOS is characterised by hyperandrogenaemia …

[HTML][HTML] Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease

C Guan, S Zahid, AS Minhas, P Ouyang, A Vaught… - Fertility and sterility, 2022 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women
of reproductive age and is hallmarked by hyperandrogenism, oligo-ovulation, and polycystic …

[HTML][HTML] Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

HF Escobar-Morreale, M Luque-Ramírez, F González - Fertility and sterility, 2011 - Elsevier
OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …

Natural molecules in the management of polycystic ovary syndrome (PCOS): an analytical review

M Iervolino, E Lepore, G Forte, AS Laganà… - Nutrients, 2021 - mdpi.com
Polycystic ovary syndrome (PCOS) is a heterogenous disorder characterized by chronic
ovulation dysfunction and hyperandrogenism. It is considered the most common …

Modulation of the inflammatory response in polycystic ovary syndrome (PCOS)—searching for epigenetic factors

D Szukiewicz, S Trojanowski, A Kociszewska… - International journal of …, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of
reproductive age. Despite its incidence, the syndrome is poorly understood and remains …